Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis.

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Juvenile idiopathic arthritis-associated uveitis (JIA-U) can lead to poor visual outcomes and impact a child's quality of life (QOL) and function. Our aim is to identify risk markers of JIA-U and examine differences in the QOL of children with JIA and JIA-U.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Juvenile idiopathic arthritis.

          Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Measurement of health status in children with juvenile rheumatoid arthritis.

            To develop and validate a self- or parent-administered instrument for measuring functional status in children with juvenile rheumatoid arthritis (JRA). We adapted the Stanford Health Assessment Questionnaire (HAQ) for use in children ages 1-19 years, by adding several new questions, such that for each functional area, there was at least 1 question relevant to children of all ages. The face validity of the instrument was evaluated by a group of 20 health professionals and parents of 22 healthy children. The questionnaire was then administered to parents of 72 JRA patients (mean age 9.1 years, onset type systemic in 16, polyarticular in 21, pauciarticular in 35). The instrument showed excellent internal reliability (Cronbach's alpha = 0.94), with a mean inter-item correlation of 0.6. The convergent validity was demonstrated by strong correlations of the Disability Index (average of scores on all functional areas) with Steinbrocker functional class (Kendall's tau b = 0.77, P 8 years) was 0.84 (n = 29; P 0.9 by paired t-test; Spearman's correlation coefficient = 0.8, P < 0.002). The Childhood HAQ, which takes less than 10 minutes to complete, is a valid, reliable, and sensitive instrument for measuring functional status in children with JRA.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.

              To analyse the prevalence and complications of uveitis and their predictors in a large cohort of patients with juvenile idiopathic arthritis (JIA). Data of 3271 JIA patients as classified by International League of Associations for Rheumatology (ILAR) criteria included in a national database during 1 yr were analysed. Uveitis prevalence was 12% of all JIA patients. The most frequent were oligoarthritis extended (25%) and persistent (16%). JIA patients with uveitis were significantly younger at onset of arthritis (3.8 vs 7.0 yrs) or ANA-positive (86% vs 42%) than the patients without uveitis. Predictors of uveitis included age at onset (P= 0.03) and ANA-positivity (P< 0.01) besides the presence of a certain JIA subgroup (P= 0.04). Uveitis was clinically silent in 75% of the oligoarthritis but in none of the enthesitis-related arthritis patients. The median onset of uveitis was 5.5 months after arthritis manifestation. In 73%, 77% and 90%, uveitis developed within 1, 2 and 4 yrs after arthritis, respectively. Anterior uveitis was the most common anatomic type of uveitis (83%). Uveitis complications at mean follow-up of 5.6 yrs were common (56%), and predictors for complications included presence of complications at first visit (P< 0.001) and uveitis manifestation before arthritis (P= 0.001), but not ANA positivity. The JIA subgroups markedly differ with respect to the prevalence and course of associated uveitis. Ophthalmological screening should be initiated early after arthritis onset and the intervals be related to the JIA subgroup. A modification of the current screening guidelines is suggested.
                Bookmark

                Author and article information

                Journal
                Pediatr Rheumatol Online J
                Pediatric rheumatology online journal
                Springer Science and Business Media LLC
                1546-0096
                1546-0096
                Jun 02 2015
                : 13
                Affiliations
                [1 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. sangele@emory.edu.
                [2 ] Children's Healthcare of Atlanta, 1405 Clifton Rd, Atlanta, GA, 30329, USA. sangele@emory.edu.
                [3 ] Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Rd, Atlanta, GA, 30322, USA. sangele@emory.edu.
                [4 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. courtney.mccracken@emory.edu.
                [5 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. steven.yeh@emory.edu.
                [6 ] Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Rd, Atlanta, GA, 30322, USA. steven.yeh@emory.edu.
                [7 ] Children's Healthcare of Atlanta, 1405 Clifton Rd, Atlanta, GA, 30329, USA. Kirsten.Jenkins@choa.org.
                [8 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. daneka.stryker@emory.edu.
                [9 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. kelly.a.rouster-stevens@emory.edu.
                [10 ] Children's Healthcare of Atlanta, 1405 Clifton Rd, Atlanta, GA, 30329, USA. kelly.a.rouster-stevens@emory.edu.
                [11 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. lvogler@emory.edu.
                [12 ] Children's Healthcare of Atlanta, 1405 Clifton Rd, Atlanta, GA, 30329, USA. lvogler@emory.edu.
                [13 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. scott.lambert@emory.edu.
                [14 ] Department of Ophthalmology, Emory University School of Medicine, 1365-B Clifton Rd, Atlanta, GA, 30322, USA. scott.lambert@emory.edu.
                [15 ] Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA. cdrews@emory.edu.
                [16 ] Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. sprahal@emory.edu.
                [17 ] Children's Healthcare of Atlanta, 1405 Clifton Rd, Atlanta, GA, 30329, USA. sprahal@emory.edu.
                [18 ] Department of Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA. sprahal@emory.edu.
                Article
                10.1186/s12969-015-0018-8
                10.1186/s12969-015-0018-8
                4450472
                26031738
                356a5187-ac0c-4ef6-9cc0-383114c496a1
                History

                Comments

                Comment on this article

                scite_

                Similar content389

                Cited by28

                Most referenced authors310